Precision Medicine market continues to demonstrate strong momentum within the healthcare and life sciences landscape. Valued at USD 130,400 million in 2024, the market is projected to reach USD 256,430 million by 2031, expanding at a compound annual growth rate (CAGR) of 10.4% during the forecast period. This robust expansion highlights the growing shift toward individualized...
The Artificial Intelligence (AI) in Precision Medicine Market research report has been crafted with the most advanced and best tools to collect, record, estimate, and analyze market data. The report also sheds light on the market overview in its entirety touching diverse aspects like product definition, prevailing vendor landscape, and market segmentation. Through the comprehensive and...
According to a newly published market research report by 24LifeSciences, global clinical LC-MS market was valued at USD 1.03 billion in 2024 and is projected to reach USD 1.69 billion by 2031, growing at a compound annual growth rate (CAGR) of 7.4% during the forecast period 2025-2031.
Liquid chromatography-mass spectrometry (LC-MS), clinically known as the gold standard for clinical...
The global Aspiration and Biopsy Needles marketis witnessing steady expansion driven by rising demand for minimally invasive diagnostic procedures, increasing cancer prevalence, and technological advancements in medical devices. According to The Insight Partners, the market size is expected to grow from US$ 1.03 Billion in 2025 to US$ 1.33 Billion by 2034, registering a CAGR...
The antisense therapy sector is emerging as a transformative segment within nucleic acid-based therapeutics, driven by advancements in genetic research, increasing prevalence of rare and chronic diseases, and rising demand for precision medicine. Antisense oligonucleotide technologies are gaining strong clinical acceptance due to their ability to selectively target disease-causing mRNA...
Neurofibromatosis is a rare genetic disorder characterized by the growth of tumors along nerves in the skin, brain, and other parts of the body. The increasing prevalence of rare neurological disorders, advancements in targeted therapies, and rising investments in orphan drug development are driving significant growth in the neurofibromatosis drugs industry. Pharmaceutical companies are...
The global precision cancer diagnostic tests market is witnessing remarkable growth due to the increasing demand for personalized medicine, advancements in molecular diagnostics, and rising cancer prevalence worldwide. Precision cancer diagnostics play a critical role in identifying genetic mutations, biomarkers, and molecular characteristics of tumors, enabling healthcare providers to develop...
The Precision Medicine market has moved from scientific concept to clinical reality over the past decade. Instead of prescribing treatments based solely on broad population averages, healthcare providers increasingly tailor therapies according to an individual’s genetic profile, environment, and lifestyle. The result? More targeted interventions, improved outcomes, and fewer...
The Evolving Landscape of Rare Disease Genetic Testing
Rare disease genetic testing is rapidly transforming modern healthcare, shifting diagnosis from a prolonged, uncertain process to a data-driven, precise science. With more than 7,000 rare diseases affecting millions globally, timely and accurate diagnosis has long been a challenge. Today, advances in genomics, artificial intelligence, and...
Russian 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Tiếng Việt